Follicular acneiform eruption induced by imatinib

Martín, J. Pérez; Jordá, Esperanza; Monteagudo, Carlos; Alonso, Vicent; Garcia, L. F. Fernandez; Villalón, Guillermo

doi:10.1111/j.1468-3083.2006.01723.x

Cited by 13 publications

(1 citation statement)

References 7 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Our literature review showed only a case of acne rosacea and another case of follicular acneiform rash attributed to this agent. 6,7 We report the first patient with cystic acne due to imatinib therapy. This cutaneous reaction had a Naranjo nomogram score of 6, indicating a probable adverse drug reaction to imatinib.…”

Section: Discussionmentioning

confidence: 97%

Cystic acne due to imatinib therapy for chronic myelocytic leukemia

Hwang

Iskandar

Rosario

et al. 2018

J Oncol Pharm Pract

View full text Add to dashboard Cite

Imatinib mesylate is a tyrosine kinase inhibitor used in the treatment of several malignancies. Its use, however, is associated with a number of toxic effects including adverse cutaneous reactions. Herein, we present a case of facial cystic acne in a patient receiving imatinib therapy for chronic myelocytic leukemia. This side effect resolved with cessation of therapy. To the best of our knowledge, this clinical entity has never been previously reported in the medical literature.

show abstract

Section: Discussionmentioning

confidence: 97%

Cystic acne due to imatinib therapy for chronic myelocytic leukemia

Hwang

Iskandar

Rosario

et al. 2018

J Oncol Pharm Pract

View full text Add to dashboard Cite

show abstract

Benign Cutaneous Adverse Reactions to Drugs

Ardern‐Jones

Lee

2016

Rook's Textbook of Dermatology, Ninth Edition

View full text Add to dashboard Cite

Adverse drug reactions commonly involve the skin and represent a significant proportion of all drug‐induced illnesses. There is a broad spectrum of phenotypes encountered in cutaneous adverse reactions and many can mimic other inflammatory rashes. Rarely, drug hypersensitivity dermatoses can be life threatening and involve internal organs; however, most eruptions are mild, affect the skin only and are self‐limiting on drug withdrawal. These disorders can be considered as the benign cutaneous adverse reactions.

show abstract

Current awareness: Pharmacoepidemiology and drug safety

2007

Pharmacoepidemiology and Drug

View full text Add to dashboard Cite

In order to keep subscribers up‐to‐date with the latest developments in their field, John Wiley & Sons are providing a current awareness service in each issue of the journal. The bibliography contains newly published material in the field of pharmacoepidemiology and drug safety. Each bibliography is divided into 20 sections: 1 Reviews; 2 General; 3 Anti‐infective Agents; 4 Cardiovascular System Agents; 5 CNS Depressive Agents; 6 Non‐steroidal Anti‐inflammatory Agents; 7 CNS Agents; 8 Anti‐neoplastic Agents; 9 Haematological Agents; 10 Neuroregulator‐Blocking Agents; 11 Dermatological Agents; 12 Immunosuppressive Agents; 13 Autonomic Agents; 14 Respiratory System Agents; 15 Neuromuscular Agents; 16 Reproductive System Agents; 17 Gastrointestinal System Agents; 18 Anti‐inflammatory Agents ‐ Steroidal; 19 Teratogens/fetal exposure; 20 Others. Within each section, articles are listed in alphabetical order with respect to author. If, in the preceding period, no publications are located relevant to any one of these headings, that section will be omitted.

show abstract

Follicular acneiform eruption induced by imatinib

Cited by 13 publications

References 7 publications

Cystic acne due to imatinib therapy for chronic myelocytic leukemia

Cystic acne due to imatinib therapy for chronic myelocytic leukemia

Benign Cutaneous Adverse Reactions to Drugs

Current awareness: Pharmacoepidemiology and drug safety

Contact Info

Product

Resources

About